Opko
In Brief This Week: Labcorp, Lucid Diagnostics, Seegene, Babson Diagnostics, Danaher, More
News items for the in vitro diagnostics industry for the week of May 8, 2022.
Opko Health Q1 Revenues Slide 40 Percent on Lower COVID Testing Volume
The drop in total revenues was driven by a decrease in diagnostics revenues, and the firm missed Wall Street estimates on the top and bottom lines.
360Dx Top 30 Falls Slightly in March
Of the 30 companies in the index, 17 saw declines in their stock prices, while 13 saw share price increases.
Opko Health Posts 19 Percent Drop in Q4 Revenues on COVID-19 Testing Decline
Despite the revenue fall, which was largely driven by a continued slide in COVID-19 testing volume, Opko topped Wall Street analysts' consensus estimate.
The purchase of GeneDx from Opko Health will help Sema4 accelerate its push into whole-exome sequencing and grow in rare disease diagnostics.
Jan 18, 2022
Sema4 to Acquire GeneDx for $623M
Oct 28, 2021
Opko Health Q3 Revenues Fall 10 Percent
Oct 30, 2020